tiprankstipranks
Theralase Reports Q1 Financials; Investor Call Ahead
Company Announcements

Theralase Reports Q1 Financials; Investor Call Ahead

Theralase Technologies (TSE:TLT) has released an update.

Pick the best stocks and maximize your portfolio:

Theralase Technologies Inc., a clinical stage pharmaceutical company, has published its first-quarter 2024 financial results showing a decrease in total revenue by 15% compared to the previous year, with significant drops in both Canadian and U.S. markets. The company reported a 33% decline in gross margin, but operating expenses also fell by 11%, leading to a 10% reduction in net loss. An investor conference call to discuss these results is scheduled for June 6th, 2024.

For further insights into TSE:TLT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskTheralase Expands US Bladder Cancer Study Sites
TipRanks Canadian Auto-Generated NewsdeskTheralase Expands Clinical Trial for Bladder Cancer
TipRanks Canadian Auto-Generated NewsdeskTheralase Expands Cancer Study with Promising Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App